General pharmacological studies on Biapenem
General pharmacological properties of biapenem (BIPM), a new carbapenem antibiotic, were studiedand the following results were obtained. 1. BIPM at doses of 10-1000mg/kg i.v. caused no influences on the gross behavior of mice.Neither 30 nor 100 mg/kg i.v. of BIPM affected the spontaneous motor activ...
Saved in:
| Published in | CHEMOTHERAPY Vol. 42; no. Supplement4; pp. 216 - 228 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English Japanese |
| Published |
Japanese Society of Chemotherapy
1994
公益社団法人 日本化学療法学会 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0009-3165 1884-5894 |
| DOI | 10.11250/chemotherapy1953.42.Supplement4_216 |
Cover
| Abstract | General pharmacological properties of biapenem (BIPM), a new carbapenem antibiotic, were studiedand the following results were obtained. 1. BIPM at doses of 10-1000mg/kg i.v. caused no influences on the gross behavior of mice.Neither 30 nor 100 mg/kg i.v. of BIPM affected the spontaneous motor activity, thiopental-induced hypnosis and pentylenetetrazole strychnine-and electroshock-induced convulsive reactions in mice. Furthermore, the same doses of BIPM showed no effects on normal body temperature and pressure-pain threshold in the inflamed paw of rats. BIPM at a dose of 300 mg/kg i.v. had no influences on the spontaneous EEG pattern in rabbits and at doses up to 600 mg/kg i.v. had no potentiation of pentylenetetrazole-induced convulsive activity in mice. In addition, intracerebroventricular injection of BIPM at doses up to 300 μg/animal did not produce behavioral changes in mice. By contrast, imipenem/cilastatin sodium at a dose of 150/150 mg/kg i.v. and above potentiated the pentylenetetrazole-induced convulsive activity and imipenem injected intracerebroventricularly at a dose of 10 μg/animal and above elicited convulsive behaviors in mice. 2. BIPM at a dose of 100 mg/kg i.v. slightly caused a decrease followed by a increase in blood pressure and increases in heart rate and femoral arterial blood flow without any changes in ECG and respiratory movement in anesthetized dogs, whereas this compound at a dose of 30 mg/kg i.v. elicited no effects on parameters. BIPM at a concentration of 10 -4M exerted no influences on contractile force, beating rate and coronary flow of isolated perfused rat hearts. 3. BIPM at a concentration of 10-4 g/ml (2.9 × 10-4M) did not influence the spontaneous motility and the contractile responses induced by acetylcholine, histamine, serotonin and barium chloride of isolated guinea pig ileums. Furthermore, BIPM at doses up to 100 mg/kg i.v. showed no effects on propulsion of gastrointestinal tract in mice and on airway resistance in anesthetized guinea pigs. 4. BIPM at doses up to 100mg/kg i.v.showed no influences on urine volume and Na+, K+and Cl-excretion in rats. A delay of BSP excretion in rats were observed at 100 mg/kg i.v. of BIPM, but notat 30 mg/kg i. v. 5. BIPM at a concentration of 10-4M did not influence the platelet aggregation by ADP and collagen, the plasma coagulation and the hemolysis test in rabbits. These findings suggest that BIPM seems to be much less potent than imipenem/cilastatin sodium in inducing proconvulsive activity and has no remarkable adverse actions regarding this general pharmacological study. |
|---|---|
| AbstractList | General pharmacological properties of biapenem (BIPM), a new carbapenem antibiotic, were studiedand the following results were obtained. 1. BIPM at doses of 10-1000mg/kg i.v. caused no influences on the gross behavior of mice.Neither 30 nor 100 mg/kg i.v. of BIPM affected the spontaneous motor activity, thiopental-induced hypnosis and pentylenetetrazole strychnine-and electroshock-induced convulsive reactions in mice. Furthermore, the same doses of BIPM showed no effects on normal body temperature and pressure-pain threshold in the inflamed paw of rats. BIPM at a dose of 300 mg/kg i.v. had no influences on the spontaneous EEG pattern in rabbits and at doses up to 600 mg/kg i.v. had no potentiation of pentylenetetrazole-induced convulsive activity in mice. In addition, intracerebroventricular injection of BIPM at doses up to 300 μg/animal did not produce behavioral changes in mice. By contrast, imipenem/cilastatin sodium at a dose of 150/150 mg/kg i.v. and above potentiated the pentylenetetrazole-induced convulsive activity and imipenem injected intracerebroventricularly at a dose of 10 μg/animal and above elicited convulsive behaviors in mice. 2. BIPM at a dose of 100 mg/kg i.v. slightly caused a decrease followed by a increase in blood pressure and increases in heart rate and femoral arterial blood flow without any changes in ECG and respiratory movement in anesthetized dogs, whereas this compound at a dose of 30 mg/kg i.v. elicited no effects on parameters. BIPM at a concentration of 10 -4M exerted no influences on contractile force, beating rate and coronary flow of isolated perfused rat hearts. 3. BIPM at a concentration of 10-4 g/ml (2.9 × 10-4M) did not influence the spontaneous motility and the contractile responses induced by acetylcholine, histamine, serotonin and barium chloride of isolated guinea pig ileums. Furthermore, BIPM at doses up to 100 mg/kg i.v. showed no effects on propulsion of gastrointestinal tract in mice and on airway resistance in anesthetized guinea pigs. 4. BIPM at doses up to 100mg/kg i.v.showed no influences on urine volume and Na+, K+and Cl-excretion in rats. A delay of BSP excretion in rats were observed at 100 mg/kg i.v. of BIPM, but notat 30 mg/kg i. v. 5. BIPM at a concentration of 10-4M did not influence the platelet aggregation by ADP and collagen, the plasma coagulation and the hemolysis test in rabbits. These findings suggest that BIPM seems to be much less potent than imipenem/cilastatin sodium in inducing proconvulsive activity and has no remarkable adverse actions regarding this general pharmacological study. General pharmacological properties of biapenem (BIPM), a new carbapenem antibiotic, were studiedand the following results were obtained.1. BIPM at doses of 10-1000mg/kg i.v. caused no influences on the gross behavior of mice.Neither 30 nor 100 mg/kg i.v. of BIPM affected the spontaneous motor activity, thiopental-induced hypnosis and pentylenetetrazole strychnine-and electroshock-induced convulsive reactions in mice. Furthermore, the same doses of BIPM showed no effects on normal body temperature and pressure-pain threshold in the inflamed paw of rats. BIPM at a dose of 300 mg/kg i.v. had no influences on the spontaneous EEG pattern in rabbits and at doses up to 600 mg/kg i.v. had no potentiation of pentylenetetrazole-induced convulsive activity in mice. In addition, intracerebroventricular injection of BIPM at doses up to 300 μg/animal did not produce behavioral changes in mice. By contrast, imipenem/cilastatin sodium at a dose of 150/150 mg/kg i.v. and above potentiated the pentylenetetrazole-induced convulsive activity and imipenem injected intracerebroventricularly at a dose of 10 μg/animal and above elicited convulsive behaviors in mice.2. BIPM at a dose of 100 mg/kg i.v. slightly caused a decrease followed by a increase in blood pressure and increases in heart rate and femoral arterial blood flow without any changes in ECG and respiratory movement in anesthetized dogs, whereas this compound at a dose of 30 mg/kg i.v. elicited no effects on parameters. BIPM at a concentration of 10 -4M exerted no influences on contractile force, beating rate and coronary flow of isolated perfused rat hearts.3. BIPM at a concentration of 10-4 g/ml (2.9 × 10-4M) did not influence the spontaneous motility and the contractile responses induced by acetylcholine, histamine, serotonin and barium chloride of isolated guinea pig ileums. Furthermore, BIPM at doses up to 100 mg/kg i.v. showed no effects on propulsion of gastrointestinal tract in mice and on airway resistance in anesthetized guinea pigs.4. BIPM at doses up to 100mg/kg i.v.showed no influences on urine volume and Na+, K+and Cl-excretion in rats. A delay of BSP excretion in rats were observed at 100 mg/kg i.v. of BIPM, but notat 30 mg/kg i. v.5. BIPM at a concentration of 10-4M did not influence the platelet aggregation by ADP and collagen, the plasma coagulation and the hemolysis test in rabbits.These findings suggest that BIPM seems to be much less potent than imipenem/cilastatin sodium in inducing proconvulsive activity and has no remarkable adverse actions regarding this general pharmacological study. Biapenem (BIPM) の一般薬理作用を検討し, 以下の成績を得た。1. BIPMは, 10~1000mg/kgの静脈内投与でマウスの一般症状に何ら影響を与えず, 100mg/kgの静脈内投与でマウスの自発運動量, thiopental睡眠, 種々の誘発痙攣, ラットの正常体温に影響を与えず, 鎮痛作用も示さなかった。また, 300mg/kg静脈内投与でウサギの自発脳波および行動に何ら影響を及ぼさず, 600mg/kgでマウスでのpentylenetetrazole誘発痙攣増強作用を示さなかった。さらに, マウスに300μg/animal脳室内投与しても行動変化をきたさなかった。一方, imipenem/cilastatin sodiumは, 10/10~300/300mg/kgの静脈内投与でマウス一般症状に影響を与えなかったが, 150/150mg/kg以上の静脈内投与でマウスpentylenetetrazele誘発痙攣を増強し, またimipenemは10μg/animal以上の脳室内投与でマウスに痙攣を惹起した。2. BIPMは, 麻酔犬で100mg/kg静脈内投与により軽度な血圧低下とその後の上昇, 心拍数および大腿動脈血流量の増加を示したが. 呼吸, 心電図には影響を与えず, 30mg/kgでは何ら影響を及ぼさなかった。10-4Mの濃度で. ラット摘出灌流心臓標本に対して影響を与えなかった。3. BIPMは, 10-4g/ml (2.9×10-4M) の濃度でモルモット摘出回腸標本に対して影響を与えず, 100mg/kgの静脈内投与でマウス小腸輸送能, 麻酔モルモット気道抵抗に影響を及ぼさなかった。4. BIPMは, 100mg/kgの静脈内投与でラットでのBSP排泄を遅延させたが, 尿量および尿中電解質排泄に影響を及ぼさなかった。5. BIPMは, 10-4Mの濃度でウサギの血小板凝集および血液凝固に影響を与えず, ウサギ赤血球で溶血性を示さなかった。以上, BIPMの痙攣誘発作用はimipenem/cilastatin sodiumに比較して著しく弱く, また一部で観察された作用も大量投与でのみ発現していることから, 特に問題となるような薬理作用は無いと考えられた。 |
| Author | Shiba, Toshiharu Kitazumi, Kazuhiro Ishikawa, Tomokazu Yanaka, Masao Shikata, Yoshiyuki Ito, Mami |
| Author_FL | 四方 義幸 石川 智一 柴 富志治 北角 和浩 谷中 正男 伊藤 真美 |
| Author_FL_xml | – sequence: 1 fullname: 柴 富志治 – sequence: 2 fullname: 北角 和浩 – sequence: 3 fullname: 石川 智一 – sequence: 4 fullname: 谷中 正男 – sequence: 5 fullname: 四方 義幸 – sequence: 6 fullname: 伊藤 真美 |
| Author_xml | – sequence: 1 fullname: Shiba, Toshiharu organization: Biological Research Laboratories, Lederle (Japan) Ltd – sequence: 1 fullname: Shikata, Yoshiyuki organization: Biological Research Laboratories, Lederle (Japan) Ltd – sequence: 1 fullname: Ishikawa, Tomokazu organization: Biological Research Laboratories, Lederle (Japan) Ltd – sequence: 1 fullname: Yanaka, Masao organization: Biological Research Laboratories, Lederle (Japan) Ltd – sequence: 1 fullname: Kitazumi, Kazuhiro organization: Biological Research Laboratories, Lederle (Japan) Ltd – sequence: 1 fullname: Ito, Mami organization: Biological Research Laboratories, Lederle (Japan) Ltd |
| BackLink | https://cir.nii.ac.jp/crid/1390001206285330304$$DView record in CiNii |
| BookMark | eNpdkE9PwzAMxSM0JMbYd9iBG3Qkzp82R5hgIE3iAJxDljpbpjat2u6wb0-mcZh2sfXkn5_sd0tGsYlIyCOjc8ZA0ie3xboZttjZ9sC05HMB869921ZYYxyEAaauyJgVhchkocWIjCmlOuNMyRsy7fuwppQxqqCAMXlYYkxO1azd2q62rqmaTXBJ98O-DNjPmjh7CbZNVH1Hrr2tepz-9wn5eXv9Xrxnq8_lx-J5le1A8CHLlfQeLQUPGotyrawuuefgVa4QgFtb8jSmrgCVl1pqic55BsjXOQqn-ITcn3xjCMaFY2VcpycYHK-WnFNORcJ-T9iuH-wGTduF2nYHY7shuArNZU5GgDnP6UKm2M5WbWcw8j_lY3G- |
| ContentType | Journal Article |
| Copyright | Japanese Society of Chemotherapy |
| Copyright_xml | – notice: Japanese Society of Chemotherapy |
| DBID | RYH |
| DOI | 10.11250/chemotherapy1953.42.Supplement4_216 |
| DatabaseName | CiNii Complete |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| DocumentTitleAlternate | Biapenemの一般薬理作用 |
| DocumentTitle_FL | Biapenemの一般薬理作用 |
| EISSN | 1884-5894 |
| EndPage | 228 |
| ExternalDocumentID | 130004198716 article_chemotherapy1953_42_Supplement4_42_Supplement4_216_article_char_en |
| GroupedDBID | 53G ADBBV ALMA_UNASSIGNED_HOLDINGS BAWUL DIK JSF JSH KQ8 RJT RZJ ZOHVM RYH |
| ID | FETCH-LOGICAL-j243t-765ffea02f29e8db6a9d3f32f676e223aad3ea00c8267d9595eccf12e3b7e4c63 |
| ISSN | 0009-3165 |
| IngestDate | Thu Jun 26 21:31:27 EDT 2025 Wed Sep 03 06:08:54 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Issue | Supplement4 |
| Language | English Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j243t-765ffea02f29e8db6a9d3f32f676e223aad3ea00c8267d9595eccf12e3b7e4c63 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/chemotherapy1953/42/Supplement4/42_Supplement4_216/_article/-char/en |
| PageCount | 13 |
| ParticipantIDs | nii_cinii_1390001206285330304 jstage_primary_article_chemotherapy1953_42_Supplement4_42_Supplement4_216_article_char_en |
| PublicationCentury | 1900 |
| PublicationDate | 1994-00-00 |
| PublicationDateYYYYMMDD | 1994-01-01 |
| PublicationDate_xml | – year: 1994 text: 1994-00-00 |
| PublicationDecade | 1990 |
| PublicationTitle | CHEMOTHERAPY |
| PublicationTitleAlternate | Chemother. |
| PublicationTitle_FL | CHEMOTHERAPY Chemother |
| PublicationYear | 1994 |
| Publisher | Japanese Society of Chemotherapy 公益社団法人 日本化学療法学会 |
| Publisher_xml | – name: Japanese Society of Chemotherapy – name: 公益社団法人 日本化学療法学会 |
| References | 1) Ubukata K, Hikida M, Yoshida M, Nishiki K, Furukawa Y, Tashiro K, Konno M and Mitsuhashi S: In vitro activity of LJC 10, 627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob Agent Chemother 34: 994-1000, 1990 5) Sawyer C H, Everett J W and Green J D: The rabbit diencephalon in stereotaxic coordinates. J comp Neurol 101: 801-824, 1954 9) 大野行弘, 広瀬彰, 辻良三, 加藤照文, 中村三孝, Edwards JR, Patel JB: 新規カルバペネム系抗生物質Meropenemの中枢作用に関する行動薬理学的および脳波学的検索. Chemotherapy 40 (S-D: 175-181, 1992 2) 疋田宗生, 森眞彦, 橘田多美: L-627 (Biapenem) のin vitro評価. Chemotherapy 42 (S-4): 91-101, 1994 4) Haley L J and Mc Cormic WG: Pharmacological effects produced by intracerebral invection of drugs in the conscious mouse. Brit J Pharmacol 12: 12-15, 1957 8) 牧栄二, 大村一平. 成瀬友裕, 池田宜二, 浅見照美: 新しいβ-ラクタム系抗生物質lmipenem (MK-0787) とDehydropeptidase-Iの特異的阻害剤Cilastatin Sodium (MK-0791) の併用時における一般薬理作用. Chemotherapy33 (S-4): 329-356, 1985 10) Calandra GB, Brown BK, Grad LC, Ahonkhai V, Wang C and Aziz MA: Review of adverse experiences and tolerability in the first 2, 516 patients treated with imipenem/cilastatin. Am J Med 78 (Suppl. 6A): 73-78, 1985 6) Konzett H and Rössler R: Versuchsanordnung zu untersuchungen an der bronchialmuskulatur. Naunyn-Schmiedeberg's Arch Exp Path Pharmak 195: 71-74, 1940 7) 浅岡宏康, 八巻芳夫, 井沢正典, 杉山史郎, 柴崎義明, 柴田右一, 武田植人, 小枝武美: Amfenacsodium (AHR-5850) の一般薬理作用 (第2報), 摘出平滑筋および消化器系などに及ぼす影響. 応用薬理25: 775-795, 1983 11) Kamei C, Kitazumi K, Tsujimoto S, Yoshida T and Tasaka K: Comparative study of certain antibiotics on epileptogenic property, including (1 Rpi, 5S, 6S)-2-[(6, 7-dihydro-5H-pyrazolo [1, 2-a][1, 2, 4] triazolium-6-yl)] thio-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate (LJC 10, 627), a carbapenem antibiotic with broad antimicrobial spectrum. J Pharmacobio-Dyn 14: 509-517, 1991 3) Hikida M, Kawashima K, Nishiki K, Furukawa F, Nishizawa K, Saito I and Kuwao S: Renal dehydropeptidase-I stability of LJC 10, 627, a new carbapenem antibiotic. Antimicrob Agent Chemother 36: 481-483, 1992 13) 中島光好, 他: 新規静注用抗生剤L-627 (Biapenem) の臨床第I相試験-L-627およびその代謝物の体内動態と安全性の検討-. 薬理と治療22: 1879-1895, 1994 |
| References_xml | – reference: 13) 中島光好, 他: 新規静注用抗生剤L-627 (Biapenem) の臨床第I相試験-L-627およびその代謝物の体内動態と安全性の検討-. 薬理と治療22: 1879-1895, 1994 – reference: 9) 大野行弘, 広瀬彰, 辻良三, 加藤照文, 中村三孝, Edwards JR, Patel JB: 新規カルバペネム系抗生物質Meropenemの中枢作用に関する行動薬理学的および脳波学的検索. Chemotherapy 40 (S-D: 175-181, 1992 – reference: 1) Ubukata K, Hikida M, Yoshida M, Nishiki K, Furukawa Y, Tashiro K, Konno M and Mitsuhashi S: In vitro activity of LJC 10, 627, a new carbapenem antibiotic with high stability to dehydropeptidase I. Antimicrob Agent Chemother 34: 994-1000, 1990 – reference: 2) 疋田宗生, 森眞彦, 橘田多美: L-627 (Biapenem) のin vitro評価. Chemotherapy 42 (S-4): 91-101, 1994 – reference: 3) Hikida M, Kawashima K, Nishiki K, Furukawa F, Nishizawa K, Saito I and Kuwao S: Renal dehydropeptidase-I stability of LJC 10, 627, a new carbapenem antibiotic. Antimicrob Agent Chemother 36: 481-483, 1992 – reference: 4) Haley L J and Mc Cormic WG: Pharmacological effects produced by intracerebral invection of drugs in the conscious mouse. Brit J Pharmacol 12: 12-15, 1957 – reference: 10) Calandra GB, Brown BK, Grad LC, Ahonkhai V, Wang C and Aziz MA: Review of adverse experiences and tolerability in the first 2, 516 patients treated with imipenem/cilastatin. Am J Med 78 (Suppl. 6A): 73-78, 1985 – reference: 5) Sawyer C H, Everett J W and Green J D: The rabbit diencephalon in stereotaxic coordinates. J comp Neurol 101: 801-824, 1954 – reference: 8) 牧栄二, 大村一平. 成瀬友裕, 池田宜二, 浅見照美: 新しいβ-ラクタム系抗生物質lmipenem (MK-0787) とDehydropeptidase-Iの特異的阻害剤Cilastatin Sodium (MK-0791) の併用時における一般薬理作用. Chemotherapy33 (S-4): 329-356, 1985 – reference: 7) 浅岡宏康, 八巻芳夫, 井沢正典, 杉山史郎, 柴崎義明, 柴田右一, 武田植人, 小枝武美: Amfenacsodium (AHR-5850) の一般薬理作用 (第2報), 摘出平滑筋および消化器系などに及ぼす影響. 応用薬理25: 775-795, 1983 – reference: 6) Konzett H and Rössler R: Versuchsanordnung zu untersuchungen an der bronchialmuskulatur. Naunyn-Schmiedeberg's Arch Exp Path Pharmak 195: 71-74, 1940 – reference: 11) Kamei C, Kitazumi K, Tsujimoto S, Yoshida T and Tasaka K: Comparative study of certain antibiotics on epileptogenic property, including (1 Rpi, 5S, 6S)-2-[(6, 7-dihydro-5H-pyrazolo [1, 2-a][1, 2, 4] triazolium-6-yl)] thio-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem-3-carboxylate (LJC 10, 627), a carbapenem antibiotic with broad antimicrobial spectrum. J Pharmacobio-Dyn 14: 509-517, 1991 |
| SSID | ssib001106282 ssj0000626693 ssib058492509 ssib005879733 ssib008506721 |
| Score | 1.2290839 |
| Snippet | General pharmacological properties of biapenem (BIPM), a new carbapenem antibiotic, were studiedand the following results were obtained. 1. BIPM at doses of... General pharmacological properties of biapenem (BIPM), a new carbapenem antibiotic, were studiedand the following results were obtained.1. BIPM at doses of... |
| SourceID | nii jstage |
| SourceType | Publisher |
| StartPage | 216 |
| SubjectTerms | Biapenem カルバペネム系抗生物質 一般薬理 |
| Title | General pharmacological studies on Biapenem |
| URI | https://www.jstage.jst.go.jp/article/chemotherapy1953/42/Supplement4/42_Supplement4_216/_article/-char/en https://cir.nii.ac.jp/crid/1390001206285330304 |
| Volume | 42 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | CHEMOTHERAPY, 1994/12/28, Vol.42(Supplement4), pp.216-228 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1884-5894 dateEnd: 19941231 omitProxy: true ssIdentifier: ssj0000626693 issn: 0009-3165 databaseCode: KQ8 dateStart: 19530101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1884-5894 dateEnd: 20041231 omitProxy: true ssIdentifier: ssj0000626693 issn: 0009-3165 databaseCode: DIK dateStart: 19530101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfYkBAvCASIjQ3lgbeS0voryeNAQ4VpgKCTxlN0_oiaVU2qLtXE_nrOcZqkBYnBi5vGycnxnc_nO9_PhLw2TBjtQoM0o7hAiSIVJoAMybKx0YICp-BcA-ef5eSCf7oUl10Ev84uqdRQ3_4xr-R_uIr3kK8uS_YfONsSxRt4jfzFEjmM5Z143GBGD5Yd_rTPcvSbA10g4F0OS3xq0TdCHQzCl-nk9NvJ19aQ_T7LFQym5fUsR2LrLjRfwe16kQ_O8GeWr8pOlGb5HG7cK4tyjpWt-oAC5jA4h2soO5eCwwbuFD1O0O7gy3bLaL0lxC6aZLCfW5o0Qf3tz3kYWq8845iHIm7oNdqV054U1SeV1m5PvqU0ZW_-pT5Z_HfVjsYaMkT3muNCgENOcZppyaYtsS0QbRe0G3HnYBnLPXKfOueNs6A_nrXKx0H3bbDi_DSOtkvSnsTnvvUBebNpyds7tAONmis08R12w16R5z27ZfqYPGoWHMGJl54n5J4tnpIN2niwIzlBIzlBWQQbyXlGLj6cTt9PwubYjPCKclaFkRRZZmGEoy-xsVESEsMyRjMZSYvWIIBhWD3SuLKMTCISgcM4G1PLVGS5luw52S_Kwr4gAVXaGBFxxYTmegRJBtIopYWMdcQBDsgP_4Xp0mOjpM1YSHe7J-U07XF_9y_2Vu9VWOHoPiDH2Gmpzl2J65TaZ1pn_DLm4vmHf6l_SR563GvnLjsi-9VqbY_RgKzUq5rxvwCnAXTg |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=General+pharmacological+studies+on+Biapenem&rft.jtitle=CHEMOTHERAPY&rft.au=Shiba+Toshiharu&rft.au=Kitazumi+Kazuhiro&rft.au=Ishikawa+Tomokazu&rft.au=Yanaka+Masao&rft.date=1994&rft.pub=Japanese+Society+of+Chemotherapy&rft.issn=0009-3165&rft.eissn=1884-5894&rft.volume=42&rft.issue=Supplement4&rft.spage=216&rft.epage=228&rft_id=info:doi/10.11250%2Fchemotherapy1953.42.supplement4_216&rft.externalDocID=130004198716 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3165&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3165&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3165&client=summon |